Definitive Healthcare Corp. (DH)
NASDAQ: DH · IEX Real-Time Price · USD
5.50
0.00 (0.00%)
At close: May 17, 2024, 4:00 PM
5.67
+0.17 (3.09%)
After-hours: May 17, 2024, 7:32 PM EDT
Definitive Healthcare Market Cap
Definitive Healthcare has a market cap or net worth of $648.64 million as of May 17, 2024. Its market cap has decreased by -58.67% in one year.
Market Cap
648.64M
Enterprise Value
617.49M
1-Year Change
-58.67%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since the IPO on September 15, 2021, Definitive Healthcare's market cap has decreased from $4.00B to $648.64M, a decrease of -83.78%. That is a compound annual growth rate of -49.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 867.30M | - |
May 16, 2024 | 867.30M | -1.26% |
May 15, 2024 | 878.40M | 2.20% |
May 14, 2024 | 859.50M | 0.37% |
May 13, 2024 | 856.30M | 2.06% |
May 10, 2024 | 839.00M | 2.91% |
May 9, 2024 | 815.30M | -3.37% |
May 8, 2024 | 843.70M | -26.20% |
May 7, 2024 | 1.14B | -0.72% |
May 6, 2024 | 1.15B | 4.42% |
May 3, 2024 | 1.10B | 0.57% |
May 2, 2024 | 1.10B | 0.29% |
May 1, 2024 | 1.09B | 0.43% |
Apr 30, 2024 | 1.09B | -2.94% |
Apr 29, 2024 | 1.12B | 2.29% |
Apr 26, 2024 | 1.10B | 3.86% |
Apr 25, 2024 | 1.06B | -7.17% |
Apr 24, 2024 | 1.14B | -0.27% |
Apr 23, 2024 | 1.14B | -0.82% |
Apr 22, 2024 | 1.15B | 3.82% |
Apr 19, 2024 | 1.11B | 0.29% |
Apr 18, 2024 | 1.10B | -2.08% |
Apr 17, 2024 | 1.13B | -1.65% |
Apr 16, 2024 | 1.15B | 3.10% |
Apr 15, 2024 | 1.11B | -3.53% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
GH Research | 671.16M |
EyePoint Pharmaceuticals | 671.11M |
Lyell Immunopharma | 661.57M |
Savara | 660.64M |
Exscientia | 654.28M |
ArriVent BioPharma | 653.13M |
iTeos Therapeutics | 648.41M |
Mineralys Therapeutics | 647.91M |